70604-37-4

Basic information

• Product Name: L'anhydride symetrique de l'acide ε-aminocaproique N-t-BOC protege
• Synonyms: L'anhydride symetrique de l'acide ε-aminocaproique N-t-BOC protege
• CAS NO: 70604-37-4
• Molecular Weight: 444.569
• Mol File: 70604-37-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: L'anhydride symetrique de l'acide ε-aminocaproique N-t-BOC protege(CAS DataBase Reference)
• NIST Chemistry Reference: L'anhydride symetrique de l'acide ε-aminocaproique N-t-BOC protege(70604-37-4)
• EPA Substance Registry System: L'anhydride symetrique de l'acide ε-aminocaproique N-t-BOC protege(70604-37-4)

Safety Data

• Hazardous Substances Data: 70604-37-4(Hazardous Substances Data)

Upstream product

• 6404-29-1 6-(tert-butoxycarbonylamino)hexanoic acid 

Downstream Products

• 307525-67-3 7-(N-t-butyloxycarbonyl-6-aminohexanoyloxy)-5-hydroxy-2-phenylchromen-4-one 
• 1026617-74-2 6-Amino-hexanoic acid [(S)-1-((S)-1-{(R)-1-[(S)-1-((S)-1-hydrazinocarbonyl-3-methylsulfanyl-propylcarbamoyl)-3-methyl-butyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-2-phenyl-ethylcarbamoyl)-2-phenyl-ethyl]-amide 

Relevant articles and documents

"Turn-on" FRET-based luminescent iridium(iii) probes for the detection of cysteine and homocysteine

"Turn-on" FRET-based luminescent probes containing iridium(iii) complexes for the detection of Cys and Hcy have been designed and synthesized. The relationship between the steric bulk of the probe and the corresponding emission intensity enhancement towards detection of Cys and Hcy has been studied.

Compositions and methods for enhancing phagocytosis or phagocyte activity

The present invention provides a system for enhancing clearance or destruction of undesirable cells or noncellular molecular entities by tagging such cells or noncellular molecular entities with a marker that targets the cells or noncellular molecular entities for phagocytosis (phagocytic marker). The target cells can be, for example, endothelial cells, tumor cells, leukocytes, or virus-infected cells. In certain embodiments of the invention the tagging is accomplished by administering a composition comprising an antibody or ligand linked to the phagcytotic marker, wherein the antibody or ligand binds to a cell type specific marker present on or in the cell surface of a target cell. In preferred embodiments of the invention, the phagocytic marker comprises phosphatidylserine or a group derived from phosphatidylserine, thrombospondin-1, annexin I, or a derivative of any of these.